Berkshire Hathaway Spending Some Cash: What It Means
Berkshire Hathaway’s massive cash pile has long frustrated investors. Now the company is finally putting some of that...
When And How To Revise A Budget
Revising your budget at the right moments keeps finances aligned with goals. This guide covers timing, criteria, and practical tweaks.
28,655 articlesBeaten-Down GitLab Stock Revenue: Is GTLB a Buy?
The GTLB story has investors buzzing about whether a rebound is ahead. Even as revenue trends stay strong, the stock ...
Lenders Should View Reset: UAD 3.6 Sparks a Fresh Start
As UAD 3.6 rolls out, lenders should view reset as a strategic inflection point — a chance to retool data, adjust ris...
What to Look for in Kevin Warsh’s First Fed Meeting
Markets await Kevin Warsh’s first Fed policy decision amid oil price movements and a fragile housing sector. This rep...
Crypto Perps’ Future Defined by Regulator Labels and Rules
Regulators opened a public comment period to redefine how crypto perpetual futures are labeled, a move that could res...
AI Just Minted Trillion None: Four ETFs Put You in the Game
As AI spending surges, a handful of ETFs offer broad, diversified access to the AI boom. Four funds map to the AI sta...
Musashi Seimitsu Might Missing: Datacenter Power Puzzle
AI-driven datacenters are pushing power demands higher, forcing a rethink of power distribution. Analysts flag musash...
Reasons Bullish America’s Economy at 250th Birthday
On the nation’s 250th birthday, economists and market experts outline ten reasons why America’s economy looks poised ...
The Reason Keep Buying Amazon Outpaces Wall Street Skeptics
A market-minded investor argues the reason keep buying amazon hinges on a massive, pre-contracted AWS backlog and a r...
Clean Harbors' Founder Parted: What Investors Should Know
When a founder sells a portion of stock, investors often wonder if it signals trouble or opportunity. This deep dive ...
U.S. Economy Grown Faster Than Forecast, Boosting Markets
The final BEA report for 2025 shows stronger-than-expected growth across consumption and investment, setting a positi...
Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status